A Bayesian decision-theoretic design for simultaneous biomarker-based subgroup selection and efficacy evaluation

The success of drug development of targeted therapy often hinges on an appropriate selection of the sensitive patient population, mostly based on patients’ biomarker levels. At the planning stage o...